摘要
目的为超说明书用药制度的完善提出意见。方法基于对CNKI、万方数据库中与超药品说明书用药有关的相关文献内容进行分析,形成对超药品说明书用药化理论认识。结果超药品说明书用药在临床中特别普遍,主要问题存在于说明书自身、医患以及药品生产企业、药物品种剂型的限制等方面;相应对策包括通过立法明确合理超说明书用药的地位、加强对说明书制度化管理、加强对处方的审核、加强对医药企业和医药代表的管理以及建立有效的医患风险分担机制。结论在法律法规的指引下,合理的超说明书用药能够更好地医治患者的疾病,促进医学的进步。
OBJECTIVE To put forward the suggestions to improve the system of super drug instructions. METHODS Forming theoretieell understanding of super drug instructions through the analysis of literature in CNKI and Wanfang data.. RESULTS Super drug instructions are particularly prevalent in clinical medication, the reasons include instructions＂ reasons, doctors and patients and drug manufacturers ＂ reasons and pharmaceutical dosage form limitation. The corresponding countermeasures include making laws, strengthening the management of drug instructions system, strengthening the approval of prescription, strengthening the management of pharmaceutical companies and pharmaceutical representatives and establishing doctors and patients risk sharing mechanism. CONCLUSION Under the guidance of laws and regulations, reasonable super drug instructions can treat disease better and promote the progress of clinical medicine.
出处
《中国药学杂志》
CAS
CSCD
北大核心
2015年第8期735-738,共4页
Chinese Pharmaceutical Journal
关键词
超药品说明书
自主决定权
知情同意
super drug instructions
the right to self-determination
informed consent
